Evidence map›Paper›PMID 35989358›Full record

ArticleMalaria journal2022

Identification of factors associated with residual malaria transmission using school-based serological surveys in settings pursuing elimination.

Jean Marius Rakotondramanga, Inès Vigan-Womas, Laura C Steinhardt, Aina Harimanana, Elisabeth Ravaoarisoa, Tsikiniaina L Rasoloharimanana, Seheno Razanatsiorimalala, Amy Wesolowski, Milijaona Randrianarivelojosia, Benjamin Roche and 1 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Jean Marius RakotondramangaEpidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar. jean.marius.g@gmail.com.ORCID http://orcid.org/0000-0003-0490-7665
Inès Vigan-WomasImmunology of Infectious Diseases Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Laura C SteinhardtMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Aina HarimananaEpidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Elisabeth RavaoarisoaFaculty of Sciences, University of Antananarivo, Antananarivo, Madagascar.
Tsikiniaina L RasoloharimananaImmunology of Infectious Diseases Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Seheno RazanatsiorimalalaUnité de Parasitologie, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Amy WesolowskiDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Milijaona RandrianarivelojosiaUnité de Parasitologie, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Benjamin Roche *IRD, Sorbonne Université, UMMISCO, 93143, Bondy, France.
Andres Garchitorena *Epidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Institut Pasteur de Madagascar · MGCentre National de la Recherche Scientifique · FRCenters for Disease Control and Prevention · USJohns Hopkins University · USUniversity of Antananarivo · MGUniversity of Toliara · MG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTargeted research on residual malaria transmission is important to improve strategies in settings pursuing elimination, where transmission reductions prove challenging. This study aimed to detect and characterize spatial heterogeneity and factors associated with Plasmodium falciparum infections and exposure, P. falciparum apical membrane antigen 1 (PfAMA1) antibody (Ab) response, in the Central Highlands of Madagascar (CHL).

methodsFrom May to July 2014, a cross-sectional school-based survey was carried out in 182 fokontany (villages) within 7 health districts of the CHL. Rapid diagnostic tests (RDTs) and a bead-based immunoassay including PfAMA1 antigen biomarker were used to estimate malaria prevalence and seroprevalence, respectively. Local Moran's I index was used to detect spatial "hotspots". Remotely sensed environmental data-temperature, vegetation indices, land covers, and elevation-were used in multivariable mixed-effects logistic regression models to characterize factors associated with malaria infection and cumulative exposure.

resultsAmong 6,293 school-children ages 2-14 years surveyed, RDT prevalence was low at 0.8% (95% CI 0.6-1.1%), while PfAMA1 Ab seroprevalence was 7.0% (95% CI 6.4-7.7%). Hotspots of PfAMA1 Ab seroprevalence were observed in two districts (Ankazobe and Mandoto). Seroprevalence increased for children living > 5 km from a health centre (adjusted odds ratio (OR) = 1.6, 95% CI 1.2-2.2), and for those experiencing a fever episode in the previous 2 weeks (OR 1.7, 95% CI 1.2-2.4), but decreased at higher elevation (for each 100-m increase, OR = 0.7, 95% CI 0.6-0.8). A clear age pattern was observed whereby children 9-10 years old had an OR of 1.8 (95% CI 1.2-2.4), children 11-12 years an OR of 3.7 (95% CI 2.8-5.0), and children 13-14 years an OR of 5.7 (95% CI 4.0-8.0) for seropositivity, compared with younger children (2-8 years).

conclusionThe use of serology in this study provided a better understanding of malaria hotspots and associated factors, revealing a pattern of higher transmission linked to geographical barriers in health care access. The integration of antibody-assays into existing surveillance activities could improve exposure assessment, and may help to monitor the effectiveness of malaria control efforts and adapt elimination interventions.

Indexed as

MalariaMalaria, FalciparumAdolescentChildChild, PreschoolCross-Sectional StudiesHumansPlasmodium falciparumPrevalenceSeroepidemiologic StudiesAMA1AntibodyClusterEpidemiologyMadagascarMalariaPlasmodium falciparumSeroprevalenceSpatial analysis

Identifiers

PMID35989358
PMCPMC9392911
OpenAlexW4292682904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.